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uals who reported limitation in activities due to any condition were considered
having disability. Any use of CAM use in the past 12 months was derived from the
adult CAM supplement and based on 21 different types of self or practitioner-based
therapies. Our final study sample (N  23,175) consisted of adult respondents over
age 18 and who did not have any missing values for disability status or CAM.
Chi-square tests were performed to test significant group differences between dis-
ability status and any CAM use. Logistic regression was used to assess the associ-
ation between disability status and CAM use after controlling for demographic,
socio-economic, access to care, health status, and life-style risk factors. All analy-
ses adjusted for the complex survey design. RESULTS: Overall, 32% of the sample
respondents reported CAM use in the past 12 months. Nearly one-third (31%) re-
ported activity limitations. The rates of CAM use was significantly higher among
individuals with disability (38.9%) compared to those without disability (30.4%).
Results from logistic regression suggested that peoplewith a disabilitywere almost
2 times as likely to use CAM even after adjusting for other characteristics(AOR
1.96, 95%CI 1.75-2.18, p0.001).CONCLUSIONS: Individualswith disabilitieswere
more likely to use CAM use compared to individuals without disabilities. A plausi-
ble reason for greater use of CAM among individuals with disability could be due to
the failure of conventional therapies in treatment and alleviation of symptoms.
Future studies need to examine as to whether greater CAM use among those with
disability is related to failure of treatment with conventional therapies.
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OBJECTIVES: To explore the ability of claims-based utilization measures – includ-
ing traditional adherence measures, a novel measure of overlapping days supply,
and measures of asymmetrical use within a population – to detect non-medical
prescription drug use.METHODS: Prescription claims from a large employer-based
administrative claims database (MarketScan) were used to evaluate drug utiliza-
tion during the first year after an index prescription for 6 classes of drugs with a
known abuse potential and 3 classes without. Population-level measures of tradi-
tional adherence metrics (i.e., MPR and PDC) and a novel measure of overlapping
days supply (MPR:PDC ratio) were calculated for all medications. Measures of
asymmetrical use within a population were evaluated with the Lorenz curve, rep-
resenting the total drug supply used by the heaviest 1%, 5% and 50% of all users.
Each measure was used to rank order (high to low) agents across and within
classes. The resulting lists were qualitatively compared on their ability to rank
order similar or dissimilar patterns. RESULTS: The study cohort included 6,840,355
patients, mean age 48.1 years, 56.5% female. The mean MPR for drugs with known
abuse potential (0.13-0.53) was lower than for drugs without (0.72-0.84). The MPR
and PDC ranking across drugs was consistent, but the MPR:PDC and Lorenz curve
ranking showed a different pattern. In addition, several abusable drugs had the
highest mean MPR:PDC ratios (i.e., 1.14 for morphine, 1.13 for oxycodone, 1.11 for
dextroamphetamine). Percent drug use by the heaviest users was also higher for
abusable drugs (e.g., Lorenz 1% of 29.1% for acetaminophenwith codeine, 21.5% for
acetaminophen with oxycodone, and 18.4% for oxycodone). CONCLUSIONS: Pa-
tients taking drugs with a known abuse potential exhibited different utilization
patterns compared to drugs without. Measures accounting for overlapping days
supply and asymmetrical drug use within a population may be better suited to
detecting non-medical prescription drug use.
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OBJECTIVES: To explore the use of generic medicines amongst elderly in Belgium.
Therefore, market shares by volume of generic medicines for the different ATC
drug classes are calculated. Possible savings of increased use of 20 generic medi-
cines, based on the top expenditures in the off-patent market in Belgium, are
calculated.METHODS:Data on the use ofmedicines in the elderly population were
derived from a regional community pharmacy database which collects data of
dispensed prescription medicines in a selection of Belgian public pharmacies. The
variables delivered were the name, the ATC-code, the number of packages sold in
2010, the average price and the defined daily dose. Savings were calculated using
weighted average price levels for both originator and generic medicines. Three
scenarios of potential savings were calculated: a 5%, 10% or 20% increase of generic
market shares of the selected medicines. RESULTS: The generic market share for
elderly in 2010 was 23.1%, while this was 23.7% for the total Belgian population in
2009. Generic market shares for the five most important ATC drug classes (A, B, C,
M and N) varied from 8.81% for class B to 63.70% for class A. Market shares of the 20
drugs used in the exercise varied from 1.11% to 96.32%. Increasingmarket shares of
generic medicines could generate savings varying from 1.80% (5% increase) to
6.39% (20% increase) of the public expenditure on originator medicines. In a situa-
tion where generic market shares would reach 95%, estimated savings could even
be 20.15% of the public expenditure on original medicines for this selection of
medicines. CONCLUSIONS: The full potential of generic medicines in the elderly
population has not yet been realized in Belgium. Additional incentives for physi-
cians, pharmacists and patients are needed as an increased use of generic medi-
cines by elderly could generate significant savings.
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OBJECTIVES: Due to barriers such as cost, regimen complexity and perceived inef-
ficacy, a substantial percentage of patients do not conform tomedical instructions.
Onsite health centers with onsite pharmacies may improvemedication adherence
through convenient, holistic and relatively inexpensive care. Accordingly, this
study sought to evaluate the influence of these onsite pharmacies on medication
adherence. METHODS: A retrospective analysis of electronic prescribing and
claims data was performed to assessmedication adherence among employees and
their dependents that received medications from an onsite health center’s phar-
macy compared with those that used an alternative site. Specifically, the medica-
tion possession ratio (MPR) was evaluated for patients who received medication
associatedwith treatment of asthma, depression, diabetes, hypertension or hyper-
lipidemia. In addition, a subanalysis of MPR among condition management partic-
ipants was performed. RESULTS: Overall, the MPR among patients who used the
onsite health center’s pharmacy was higher than among those who used an alter-
nate source: 54.8% versus 50.7%, respectively. In particular, the MPR was signifi-
cantly (P 0.002) greater for hypertension patients who used the onsite pharmacy
compared with those who did not. In general, the longitudinal analysis did not
demonstrate significant differences between groups across time, indicating that
medication adherence was relatively consistent over the study period. Across con-
ditions, medication adherence was significantly (P  0.001) higher among patients
who participated in conditionmanagement programs than among thosewhowere
not enrolled. CONCLUSIONS: Both the onsite health center’s pharmacy and condi-
tion management program participation positively impacted medication adher-
ence among employees and their dependents.
PHP25
DERIVING PATIENT CHRONIC DISEASE CONDITIONS FROM MEDICATION
UTILIZATION USING COMBINATION OF CLINICAL RULES AND LOGISTIC
REGRESSION
Huang Z, Hou JG, Taitel M
Walgreens Co., Deerfield, IL, USA
OBJECTIVES: Pharmacists are on the frontline of health care and have the ability to
provide direct patient care in the form of prescription counseling, medication ther-
apeutic management, and patient health and wellness education. While other
healthcare providers often have access to medical records and other forms of di-
agnosis data, pharmacists typically rely on prescription dispensing data. The ab-
sence of diagnosis information from prescriptions presents a limiting factor to the
care that can be provided. This study aims to evaluate the use of a clinical rules and
predictive models to improve patient chronic disease identification.METHODS: A
retrospective analysis was conducted using de-identified pharmacy and medical
claims data covering the period for years 2007 and 2008. Patient disease conditions
were derived from pharmacy claims using Medi-Span® drug indication database.
We compared the medication-derived disease conditions to ICD-9 diagnoses ob-
tained frommedical claims. Diagnoses evaluated were: diabetes mellitus, asthma/
COPD, rheumatoid arthritis, Parkinson’s disease, human immunodeficiency virus,
multiple sclerosis, and hyperlipidemia. Multivariate logistic regression models
were built to improve the accuracy of diagnosis identification. RESULTS: Therewas
good agreement betweenmedication-derived patient disease conditions andmed-
ical claims diagnosed conditionswhile variations existed among selected diseases.
When using the medication-derived patient disease condition indicator alone as
predicator in a logistic model, predictive power as expressed in the area under
curve (AUC) for all seven diseases ranged from 0.72 to 0.90. Adding age, gender,
number of therapeutic class and drug cost as predictors to themodels significantly
improved the AUC an average of 13%, and the seven diseases ranged from 0.83 to
0.94. CONCLUSIONS: Pharmacy claims data are reasonably accurate identifiers for
chronic disease conditions when underlying conditions require specific medica-
tion treatments. Combining patient demographic information and medication-
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OBJECTIVES: Polypharmacy, defined as concurrent use of six ormoremedications,
is a critical issue in individuals with multiple chronic physical conditions. The
objective of the study is to estimate the rates and types of drug use and hence
polypharmacy among individuals with multiple chronic physical conditions and
compare these to individuals without multimorbidity. We also examine the rela-
tionship between polypharmacy and various clusters of conditions to identify the
trends of polypharmacy in particular clusters of conditions. METHODS: Cross-
sectional analysis of 9259 individuals of age above 21, with at least one chronic
physical condition in the following clusters: cardio-metabolic consisting of diabe-
tes or heart disease or hypertension, respiratory consisting of chronic obstructive
pulmonary disease or asthma and musculoskeletal consisting of osteoarthritis or
rheumatoid arthritis or osteoporosis from the 2008Medical Expenditure Panel Sur-
vey (MEPS). Chi-square tests and multivariate logistic regressions were performed
to analyze the rates and types of drug use and hence polypharmacy among various
chronic clusters. All analysis accounted for the complex survey design of theMEPS.
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